Lexpos News

MHRA Class 3 Medicines Recall: Phenoxymethylpenicillin 250mg/5ml Oral Solution Sugar Free (Kent Pharma UK) Drug alert number: EL (24)A/60 Date issued: 3 December 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 3 medicines recall notice for: Phenoxymethylpenicillin 250mg/5ml Oral Solution Sugar Free (Kent Pharma UK) DMRC reference number: DMRC-31179592 Company name: [...]

The post MHRA Class 3 Medicines Recall: Phenoxymethylpenicillin 250mg/5ml Oral Solution Sugar Free (Kent Pharma UK) appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Coal tar extract (Neutrogena® T/Gel® Therapeutic) 2% shampoo MSN/2024/111 Tier 2 – medium impact Date of issue: 3rd December 2024 Coal tar extract (Neutrogena® T/Gel® Therapeutic) 2% shampoo (all pack sizes) is being discontinued from February 2025 Alternative coal tar extract [...]

The post Medicine Supply Notification: Coal tar extract (Neutrogena® T/Gel® Therapeutic) 2% shampoo appeared first on Community Pharmacy England.

Community Pharmacy England has released a set of resources to explain the introduction of Original Pack Dispensing (OPD), including how and when it will apply. From 1st January 2025, amendments made to the pharmacy regulations state that the supervising pharmacist must consider dispensing up to 10% more or less than the prescribed quantity, as appropriate, [...]

The post Explained: the introduction of Original Pack Dispensing appeared first on Community Pharmacy England.

Community Pharmacy England has released a set of resources to explain the introduction of Original Pack Dispensing (OPD), including how and when it will apply. From 1st January 2025, amendments made to the pharmacy regulations state that the supervising pharmacist must consider dispensing up to 10% more or less than the prescribed quantity, as appropriate, [...]

The post Explained: the introduction of Original Pack Dispensing appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Defect Information: Mycophenolate Mofetil 1g/5ml Oral Suspension (Rosemont Pharmaceuticals Limited) Drug alert number: EL (24)A/59 Date issued: 2 December 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Mycophenolate Mofetil 1g/5ml Oral Suspension (Rosemont Pharmaceuticals Limited) DMRC reference number: DMRC-33616486 Company name: [...]

The post MHRA Class 4 Medicines Defect Information: Mycophenolate Mofetil 1g/5ml Oral Suspension (Rosemont Pharmaceuticals Limited) appeared first on Community Pharmacy England.